Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial

Authors: Nick Woznitza, Anand Devaraj, Samuel M. Janes, Stephen W. Duffy, Angshu Bhowmik, Susan Rowe, Keith Piper, Sue Maughn, David R. Baldwin

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Diagnostic capacity and suboptimal logistics are consistently identified as barriers to timely diagnosis of cancer, especially lung cancer. Immediate chest X-ray (CXR) reporting for patients referred from general practice is advocated in the National Optimal Lung Cancer Pathway to improve time to diagnosis of lung cancer and to reduce inappropriate urgent respiratory medicine referral for suspected cancer (2WW) referrals. The aim of radioX is to examine the impact of immediate reporting by radiographers of CXRs requested by general practice (GP) on lung cancer patient pathways.

Methods

A two-way comparative study that will compare the time to diagnosis of lung cancer for patients. Internal comparison will be made between those who receive an immediate radiographer report of a GP CXR compared to standard radiographer GP CXR reporting over a 12-month period. External comparison will be made with a similar, neighbouring hospital trust that does not have radiographer CXR reporting. Primary outcome is the effect on the speed of the lung cancer pathway (diagnosis of cancer or discharge). Secondary outcomes include the effect of the pathway on efficiency including the number of repeat CXRs performed in a timely fashion for suspected infection and the effect of immediate reporting of GP CXRs on patient satisfaction.

Discussion

The radioX trial will examine the hypothesis that immediate reporting of CXRs referred from GP reduces the time to diagnosis of lung cancer or discharge from the lung cancer pathway.

Trial registration

International Standard Randomised Controlled Trial Number ISRCTN21818068. Registered on 20 June 2017.
Appendix
Available only for authorised users
Literature
1.
International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Geneva: World Health Organisation; 2012.
2.
Office for National Statistics. Index of cancer survival for Clinical Commissioning Groups in England: Adults diagnosed 1998–2013 and followed up to 2014. London: Office for National Statistics; 2016.
3.
4.
O’Dowd EL, McKeever TM, Baldwin DR, et al. What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 2015;70(2):161–8.CrossRefPubMed
5.
Cancer Research UK. CancerStats Key Facts—Lung Cancer. In: UK C. R., ed., 2011
6.
National Institute for Health and Clinical Excellence. Lung cancer: the diagnosis and treatment of lung cancer. London: National Institute for Health and Clinical Excellence; 2011.
7.
Iyen-Omofoman B, Tata LJ, Baldwin DR, et al. Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier. Thorax. 2013;68(5):451–9.CrossRefPubMed
8.
National Institute for Health and Care Excellence. Suspected cancer: recognition and referral (NG12). London: National Institute for Health and Care Excellence; 2015.
9.
NHS England. Diagnostic Imaging Dataset Statistical Release. London: Department of Health; 2016.
10.
NHS England. Five Year Forward View. London: NHS England; 2014.
11.
Organisation for Economic Co-operation and Development. Health at a Glance: Europe 2014. Paris: OECD Publishing; 2014.
12.
Royal College of Radiologists. Clinical radiology UK workforce census 2015 report. London: Royal College of Radiologists; 2016.
13.
14.
15.
2020 Delivery. Horizon scanning: an evaluation of imaging capacity across the NHS in England. London: Cancer Research; 2015.
16.
Royal College of Radiologists. Unreported X-rays, computed tomography (CT) and magnetic resonance imaging (MRI) scans: results of a snapshot survey of English National Health Service (NHS) trusts. London: Royal College of Radiologists; 2015.
17.
Royal College of Radiologists. Unreported X-rays, computed tomography (CT) and magnetic resonance imaging (MRI) examinations: results of the September 2015 snapshot survey of English NHS acute trusts. London: Royal College of Radiologists; 2015.
18.
Royal College of Radiologists. Our patients are still waiting …. London: Royal College of Radiologists; 2016.
19.
Byrne SC, Barrett B, Bhatia R. The impact of diagnostic imaging wait times on the prognosis of lung cancer. Can Assoc Radiol J. 2015;66(1):53–7.CrossRefPubMed
20.
Snaith B, Hardy M, Lewis EF. Radiographer reporting in the UK: a longitudinal analysis. Radiography. 2015;21(2):119–23.CrossRef
21.
Woznitza N, Piper K, Rowe S, et al. Optimizing patient care in radiology through team-working: A case study. Radiography. 2014;20(3):258–63.CrossRef
22.
Snaith B, Milner R, Harris MA. Beyond image interpretation: capturing the impact of radiographer advanced practice through activity diaries. Radiography. 2016;22(4):e233–8.CrossRef
23.
Piper K, Cox S, Paterson A, et al. Chest reporting by radiographers: findings of an accredited postgraduate programme. Radiography. 2014;20(2):94–9.CrossRef
24.
Woznitza N, Piper K, Burke S, et al. Adult chest radiograph reporting by radiographers: preliminary data from an in-house audit programme. Radiography. 2014;20(3):223–9.CrossRef
25.
ACE Lung Cancer Pathway Cluster. Improving diagnostic pathways for patients with suspected lung cancer: final report. London: Macmillan, Cancer Research UK & NHS England; 2017.
26.
Pearson C, Poirier V, Peake M. Lung cancer diagnostic pathway analysis: final report. London: Cancer Research UK; 2017.
27.
Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.CrossRefPubMedPubMedCentral
28.
Taylor-Phillips S, Wallis MG, Jenkinson D, et al. Effect of using the same vs different order for second readings of screening mammograms on rates of breast cancer detection: a randomized clinical trial. J Am Med Assoc. 2016;315(18):1956–65.CrossRef
29.
Beardmore C, Woznitza N, Goodman S. The radiography workforce current challenges and changing needs. London: College of Radiographers; 2016.
30.
Taylor-Phillips S, Wallis MG, Parsons H, et al. Changing case Order to Optimise patterns of Performance in mammography Screening (CO-OPS): study protocol for a randomized controlled trial. Trials. 2014;15:17.CrossRefPubMedPubMedCentral
31.
ACE Programme. Lung cancer pathways: interim report variations in performance and practice. London: Cancer Research UK, Macmillan & NHS England; 2016.
32.
Woznitza N. The diagnostic accuracy of reporting radiographer chest x-ray interpretations and their influence on clinicians’ diagnostic decision-making: a comparison with consultant radiologists. PhD Thesis. UK: Canterbury Christ Church University; 2016.
33.
34.
Navani N, Nankivell M, Lawrence DR, et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. Lancet Respir Med. 2015;3(4):282–9.CrossRefPubMedPubMedCentral
35.
Bajre MK, Pennington M, Woznitza N, et al. Expanding the role of radiographers in reporting suspected lung cancer: a cost-effectiveness analysis using a decision tree model. Radiography. 2017;23:273–8.CrossRefPubMed
36.
Cancer Strategy Taskforce. Statement of Intent: Cancer Strategy for England: 2015–2020. London: Department of Health; 2015
Metadata
Title
Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial
Authors
Nick Woznitza
Anand Devaraj
Samuel M. Janes
Stephen W. Duffy
Angshu Bhowmik
Susan Rowe
Keith Piper
Sue Maughn
David R. Baldwin
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-2268-x

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue

Study protocol

The effectiveness and cost-effectiveness of a mindfulness training programme in schools compared with normal school provision (MYRIAD): study protocol for a randomised controlled trial

Study protocol

Current practice in methodology and reporting of the sample size calculation in randomised trials of hip and knee osteoarthritis: a protocol for a systematic review

Study protocol

A primary school active break programme (ACTI-BREAK): study protocol for a pilot cluster randomised controlled trial

Study protocol

Simulated patient encounters to improve adolescent retention in HIV care in Kenya: study protocol of a stepped-wedge randomized controlled trial

Research

The impact of active stakeholder involvement on recruitment, retention and engagement of schools, children and their families in the cluster randomised controlled trial of the Healthy Lifestyles Programme (HeLP): a school-based intervention to prevent obesity

Study protocol

Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial